Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients
Clinical trial NCT03013556 · UNKNOWN
Trial details
- NCT number
- NCT03013556
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2021-12-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.